Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹43 Cr
Revenue (TTM)
₹10 Cr
Net Profit (TTM)
₹2 Cr
ROE
0 %
ROCE
108 %
P/E Ratio
20.2
P/B Ratio
-921.6
Industry P/E
41.86
EV/EBITDA
12.3
Div. Yield
0 %
Debt to Equity
-4
Book Value
₹--
EPS
₹2.2
Face value
10
Shares outstanding
9,981,640
CFO
₹12.80 Cr
EBITDA
₹18.45 Cr
Net Profit
₹6.18 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medinova Diagno
| 16.6 | 6.8 | 6.0 | 7.4 | 20.2 | 25.5 | 2.7 |
|
BSE Healthcare*
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Medinova Diagno
| -26.3 | 84.9 | -37.1 | 52.2 | 93.9 | -21.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Medinova Diagnostic Services Limited, together with its subsidiary, Medinova Millennium MRI Services LLP, provides medical diagnostic services in India. It offers blood test, MRI/CT scan, digital X-ray, ultra-sonography, bone densitometry, 2D echo... color doppler, vascular study, cardiac stress lab, ECG, EEG, biochemistry, haematology, microbiology, and histopathology services; and home visit, lab samples, reports delivery, and ambulance services. The company also provides lipid, cardiac, hypertension, renal, hepatic, orthopedic, and rheumatoid profiles. In addition, it operates a training and research institution in Pune. The company serves company executives, government employees, industrial workers, etc., as well as people in rural and semi urban areas. It operates four centers located in Hyderabad, Kolkata, and Pune; and three franchise centers. The company was founded in 1985 and is based in Hyderabad, India. Medinova Diagnostic Services Limited is a subsidiary of Vijaya Diagnostic Centre Private Limited. Read more
Incorporated
1993
Chairman
Sura Surendranath Reddy
Managing Director
Sunil Chandra Kondapally
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Medinova Diagnostic Services Ltd is ₹43.45 (BSE) as of 24-Nov-2025 IST. Medinova Diagnostic Services Ltd has given a return of 20.15% in the last 3 years.
The P/E ratio of Medinova Diagnostic Services Ltd is 20.15 times as on 24-Nov-2025, a 52 discount to its peers’ median range of 41.86 times.
The P/B ratio of Medinova Diagnostic Services Ltd is -921.59 times as on 24-Nov-2025, a 13266 discount to its peers’ median range of 7.00 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.96
|
-30.34
|
|
2024
|
15.28
|
-9.77
|
|
2023
|
10.49
|
-3.40
|
|
2022
|
13.87
|
-4.62
|
|
2021
|
11.28
|
-3.17
|
The 52-week high and low of Medinova Diagnostic Services Ltd are Rs 46.92 and Rs 32.10 as of 02-Apr-2026.
Medinova Diagnostic Services Ltd has a market capitalisation of ₹ 43 Cr as on 24-Nov-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Medinova Diagnostic Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.56
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.